INO Similar Chart Price Prediction
The price of INO is predicted to go up 11.95%, based on the high correlation periods with OTLK. The similarity of these two price pattern on the periods is 99.27%.
INO
OTLK
Up: 11.95%Similarity: 99.27%
INO Revenue Forecast
INO EPS Forecast
INO FAQs
What is revenue forecast for next quarter？
INO Analyst's Forecast
Jay Olson
Oppenheimer
Buy
Price Target
$33 → $15
Upside
+268.1%
Oppenheimer lowered the firm's price target on Inovio to $15 from $33 and keeps an Outperform rating on the shares after the company reported Q3 financial updates and business highlights, including progress on BLA filing for INO-3107 planned for mid-2025. The firm notes that total Q3 OpEx was $27.3M, resulting in $84.8M of cash providing financial runway through Q3 2025 to support BLA submission. Oppenheimer was also encouraged by regulatory progress ex-U.S. and new immunology data that supports the biological basis for INO-3107's clinical benefit.